Distinguished in Heart Failure

David Erlinge

Lund, M, SE 
Distinguished in Heart Failure
Lund, M, SE 
OverviewLocationsClinical Research

Overview

David Erlinge practices in Lund, Sweden. Dr. Erlinge is rated as a Distinguished expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Ventricular Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 424 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 42 articles in the study of Heart Failure.

Gender
Male

Locations

Lund, M, Sweden
Other Locations
Malmoe, M, Sweden
Goeteborg, O 41345, Sweden
Lund, S 22185, Sweden
Uppsala, C, Sweden
M, Sweden
Boras, O, Sweden
St. Göran Hospital, Capio St. Görans Sjukhus, Halmstad, N, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)
IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)
Enrollment Status: Active_not_recruiting
Publish Date: September 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients With ACS- PROSPECT II (Natural History Study), Combined With a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients With ACS- PROSPECT II (Natural History Study), Combined With a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
Enrollment Status: Completed
Publish Date: August 10, 2021
Intervention Type: Device
Study Phase: Not Applicable
COOL-AMI EU PILOT TRIAL: A Multicenter, Prospective, Randomized Controlled Trial To Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With ACUTE MYOCARDIAL INFARCTION
COOL-AMI EU PILOT TRIAL: A Multicenter, Prospective, Randomized Controlled Trial To Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With ACUTE MYOCARDIAL INFARCTION
Enrollment Status: Completed
Publish Date: November 25, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

423 Total Publications

Reply to the commentary by Dong et al.: Appraising the CCTA-SCAD study: Current challenges and future perspectives in diagnosing acute spontaneous coronary artery dissection.
Reply to the commentary by Dong et al.: Appraising the CCTA-SCAD study: Current challenges and future perspectives in diagnosing acute spontaneous coronary artery dissection.
Journal: Journal of cardiovascular computed tomography
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Erlinge's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile